Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $709.17 million for the year ending 2025.
- CATALYST PHARMACEUTICALS, INC. showed an increase of +37.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), CATALYST PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 5,927.0%.
- Historical annual values: Fiscal year 2025: $709.17 million | Fiscal year 2024: $517.55 million | Fiscal year 2023: $137.64 million | Fiscal year 2022: $298.40 million | Fiscal year 2021: $171.45 million | Fiscal year 2020: $130.24 million | Fiscal year 2019: $89.51 million | Fiscal year 2018: $16.56 million | Fiscal year 2017: $57.50 million | Fiscal year 2016: $13.89 million | Fiscal year 2015: $28.24 million | Fiscal year 2014: $9.10 million | Fiscal year 2013: $2.22 million | Fiscal year 2012: $1.41 million | Fiscal year 2011: $6.03 million | Fiscal year 2010: $5.48 million | Fiscal year 2009: $7.78 million | Fiscal year 2008: $11.77 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: